Universal Health Shares Drop 21% YTD: Should You Buy Now?
UHS' 21% YTD slide has cheapened its valuation, but weaker volumes, ACA pressure and lower growth forecasts keep risks elevated.
UHS - Universal Health Services, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$193.00
DETAILS
HIGH:
$290.00
LOW:
$166.00
MEDIAN:
$189.00
CONSENSUS:
$193.00
UPSIDE:
8.57%
Stock News
UHS Adds Talkspace to Accelerate Virtual Behavioral Health Growth
Universal Health's $835M Talkspace acquisition expands virtual behavioral health, adding 6,000 providers and new growth opportunities.
Universal Health Services, Inc. Completes Acquisition of Talkspace, Inc.
Creates nation's first full continuum of behavioral healthcare services, supporting people across every stage of their mental health journey KING OF PRUSSIA, Pa. and NEW YORK, Aug. 17, 2026 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) today announced the successful completion of its acquisition of Talkspace, Inc. (NASDAQ: TALK), bringing together one of the nation's largest providers of healthcare services with a leading virtual behavioral health platform to redefine how mental healthcare is accessed and delivered.
Universal Health Services, Inc. $UHS Stock Holdings Decreased by Bank of America Corp DE
Bank of America Corp DE lowered its position in shares of Universal Health Services, Inc. (NYSE: UHS) by 23.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 260,978 shares of the health services provider's stock after selling 79,933 shares
Assenagon Asset Management S.A. Decreases Stake in Universal Health Services, Inc. $UHS
Assenagon Asset Management S.A. cut its stake in Universal Health Services, Inc. (NYSE: UHS) by 50.2% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 44,000 shares of the health services provider's stock after selling 44,340 shares during the period. Assenagon
UNIVERSAL HEALTH SERVICES INVESTOR ALERT: Haeggquist & Eck, LLP Investigates Universal Health Services' Directors and Officers for Breach of Fiduciary Duties – UHS
NEW YORK--(BUSINESS WIRE)-- #HAEclassaction--UNIVERSAL HEALTH SERVICES INVESTOR ALERT: Haeggquist & Eck, LLP Investigates Universal Health Services' Directors and Officers.
Implied Volatility Surging for Universal Health Stock Options
Investors need to pay close attention to UHS stock based on the movements in the options market lately.
Universal Health Services: Valuations Look Attractive After A Meaningful Correction
I am initiating coverage on Universal Health Services with a Buy rating and a 24-month investment horizon, citing attractive valuations. UHS's behavioral health segment offers robust EBITDA margins and geographic diversification, with growth potential from the Talkspace acquisition and UK expansion. Despite concerns from the OBBBA and recent earnings misses, UHS's strong credit profile, healthy cash flows, and low leverage support continued capital allocation flexibility.
First Trust Advisors LP Decreases Position in Universal Health Services, Inc. $UHS
First Trust Advisors LP decreased its stake in Universal Health Services, Inc. (NYSE: UHS) by 8.3% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 174,680 shares of the health services provider's stock after selling 15,819 shares during the
Is It Too Late to Buy Universal Health Services Inc (UHS) After 4.3% Rally? GF Value Says Undervalued
On July 28, 2026, Universal Health Services Inc (UHS) shares rose 4.3% to $166.22, showing a notable rebound over recent weeks. The stock has fluctuated within
Universal Health Services Q2 Earnings Call Highlights
Universal Health Services NYSE: UHS reported second-quarter adjusted earnings per share of $5.98, up 12% from a year earlier, while adjusted EBITDA less noncontrolling interests rose 5% to $678 million. The company said results benefited from a $100 million out-of-period Florida directed payment program benefit that had not been included in its original outlook.
Universal Health Services, Inc. (UHS) Q2 2026 Earnings Call Transcript
Universal Health Services, Inc. (UHS) Q2 2026 Earnings Call Transcript
UHS Beats Q2 Earnings and Revenue Estimates Despite Cost Pressures
UHS tops Q2 earnings and revenue estimates as Acute Care and Behavioral Health growth lifts results, even as higher costs weigh on operations.
Universal Health Services (UHS) Reports Q2 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Universal Health Services (UHS) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Universal Health Services (UHS) Q2 Earnings and Revenues Top Estimates
Universal Health Services (UHS) came out with quarterly earnings of $5.98 per share, beating the Zacks Consensus Estimate of $5.66 per share. This compares to earnings of $5.35 per share a year ago.
Universal Health Services cuts 2026 forecast on Medicaid reimbursement uncertainty
Hospital operator Universal Health Services lowered its full-year profit forecast on Monday, citing changes in reimbursements related to certain Medicaid supplemental payment programs, sending its shares down nearly 8% in extended trading.
UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND SIX-MONTH PERIODS ENDED JUNE 30, 2026, AND REVISES 2026 FULL YEAR OPERATING RESULTS FORECAST
Consolidated Results of Operations, As Reported and As Adjusted – Three-month periods ended June 30, 2026 and 2025: KING OF PRUSSIA, Pa., July 27, 2026 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that its reported net income attributable to UHS was $358.4 million, or $5.98 per diluted share, during the second quarter of 2026, as compared to $353.2 million, or $5.43 per diluted share, during the second quarter of 2025.
Caxton Associates LLP Makes New Investment in Universal Health Services, Inc. $UHS
Caxton Associates LLP bought a new position in shares of Universal Health Services, Inc. (NYSE: UHS) during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 4,794 shares of the health services provider's stock, valued at approximately $858,000. Other large investors have also
Allspring Global Investments Holdings LLC Trims Holdings in Universal Health Services, Inc. $UHS
Allspring Global Investments Holdings LLC lowered its stake in shares of Universal Health Services, Inc. (NYSE: UHS) by 51.6% during the undefined quarter, according to its most recent filing with the SEC. The firm owned 27,191 shares of the health services provider's stock after selling 28,932 shares during the period. Allspring Global Investments
Can Acute Care Strength Offset Universal Health's Rising Q2 Costs?
UHS heads into Q2 with higher admissions and revenue growth expected, but rising labor and operating costs may limit earnings upside.
Price Targets
Universal Health price target lowered to $183 from $190 at RBC Capital
$183.00
(was $171.80)
Ben Hendrix
·
RBC Capital
Universal Health price target lowered to $190 from $242 at Goldman Sachs
$190.00
(was $168.16)
Goldman Sachs
Universal Health price target lowered to $290 from $310 at UBS
$290.00
(was $166.22)
UBS
Universal Health Services (UHS) PT Lowered to $189 at Guggenheim
$189.00
(was $166.22)
Jason Cassorla
·
Guggenheim
Universal Health price target lowered to $166 from $204 at Baird
$166.00
(was $166.22)
Robert W. Baird
Universal Health Services (UHS) PT Lowered to $191 at Morgan Stanley
$191.00
(was $166.22)
Craig Hettenbach
·
Morgan Stanley
Universal Health price target lowered to $168 from $179 at Barclays
$168.00
(was $159.31)
Barclays
Universal Health price target lowered to $195 from $211 at Guggenheim
$195.00
(was $151.16)
Guggenheim
Universal Health price target raised to $166 from $165 at Wells Fargo
$166.00
(was $155.57)
Wells Fargo
Universal Health downgraded to Equal Weight from Overweight at Barclays
$179.00
(was $161.26)
Barclays
Universal Health resumed with an Equal Weight at Wells Fargo
$165.00
(was $146.11)
Wells Fargo
Universal Health price target lowered to $310 from $320 at UBS
$310.00
(was $167.86)
UBS
Universal Health price target lowered to $194 from $229 at Cantor Fitzgerald
$194.00
(was $167.51)
Cantor Fitzgerald
Universal Health price target lowered to $190 from $216 at RBC Capital
$190.00
(was $162.54)
RBC Capital
Universal Health price target lowered to $211 from $238 at Guggenheim
$211.00
(was $162.54)
Guggenheim
Universal Health price target lowered to $204 from $241 at Baird
$204.00
(was $162.54)
Michael Ha
·
Robert W. Baird
Universal Health price target lowered to $238 from $268 at Barclays
$238.00
(was $179.51)
Barclays
Universal Health price target lowered to $262 from $263 at Barclays
$262.00
(was $203.68)
Barclays
Universal Health price target lowered to $245 from $251 at TD Cowen
$245.00
(was $214.97)
UBS
Universal Health downgraded to Equal Weight from Overweight at Wells Fargo
$235.00
(was $221.74)
Wells Fargo